SI-BONE, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $1.19M, a 24.11% decline year-over-year.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $1.57M, a 6.52% increase year-over-year.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-12-31 was $654.00K, a 5.35% decline year-over-year.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $1.50M, a 0.00% change year-over-year.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $2.21M, a 2.46% increase from fiscal 2024.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $2.15M, a 1.69% decline from fiscal 2023.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $2.19M, a 20.52% increase from fiscal 2022.
- SI-BONE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.82M, a 22.41% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $1.19M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $2.21M 10-K · filed 2026-02-24 | |
| 2025-06-30 | $1.57M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.15M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.50M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.47M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $691.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.19M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.50M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.47M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.82M 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2022-06-30 | $1.20M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $743.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $2.34M 10-K · filed 2023-03-02 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.57M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.92M 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | |
| 2020-06-30 | $991.00K 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $903.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $2.20M 10-K · filed 2021-03-10 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | |
| 2019-06-30 | $1.26M 10-Q · filed 2020-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |